Zampilimab (UCB-7858) is a monoclonal antibody specifically targeting transglutaminase 2 (TG2). This antibody demonstrates potential utility in enhancing the outcomes of renal transplantation. Zampilimab has been developed to modulate immune responses, potentially reducing the risk of transplant rejection and improving graft survival. Its precise mechanism involves the inhibition of TG2, an enzyme implicated in inflammation and tissue fibrosis. This product is pivotal for research focused on transplant immunology and the development of therapeutic strategies to increase transplant success rates.
Zampilimab (UCB-7858) is a monoclonal antibody specifically targeting transglutaminase 2 (TG2). This antibody demonstrates potential utility in enhancing the outcomes of renal transplantation. Zampilimab has been developed to modulate immune responses, potentially reducing the risk of transplant rejection and improving graft survival. Its precise mechanism involves the inhibition of TG2, an enzyme implicated in inflammation and tissue fibrosis. This product is pivotal for research focused on transplant immunology and the development of therapeutic strategies to increase transplant success rates.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
